View More
Download this short summary slideset of key takeaway points from a live presentation on HER2 testing and how this can inform treatment in metastatic breast cancer.
Mark D. Pegram, MD
Michael F. Press, MD, PhD
Released: July 30, 2020
Download this slideset for expert perspectives on key nuances of HER2 testing in metastatic breast cancer and how test results inform HER2-targeted therapy decisions.
Mark D. Pegram, MD
Michael F. Press, MD, PhD
Released: July 30, 2020
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.